Company intelligence / Profile preview

Immuno-Vax

Bethesda, Maryland, United States
Ownership
Private
Development stage
Other
01

Overview

Immuno-Vax is a small private healthcare consulting company focused on vaccine and biologics development rather than a traditional therapeutics pipeline company. Publicly available references identify Immuno-Vax, LLC as the consulting vehicle of Peter A. Patriarca, a former FDA and CDC official with deep expertise in regulatory affairs, clinical development, and vaccine policy. The firm appears to provide technical and regulatory consulting services across vaccine and other biologics programs, including support for INDs, BLAs, and broader development strategy. Based on the available information, Immuno-Vax does not appear to operate as a venture-backed drug developer with a disclosed internal pipeline, platform, or commercial product portfolio.

Therapeutic areas
Infectious Diseases
Modalities
VaccineMonoclonal antibodymRNA-based drugsBiologic
Industry
Consulting

Beyond the preview

Go deeper on Immuno-Vax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immuno-Vax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call